Egyptian Minister of Health and Population, Mr. Khaled Abdel Ghaffar has discussed the possibilities of increasing cooperation in the health sector during a meeting with a delegation of UAE’s G42 Healthcare.
The spokesman for the Egyptian Health Ministry stated that the minister was briefed on the Emirati company’s profile and its achievements in the past period.
“G42 Healthcare has a large laboratory for analyzing 100,000 samples a year. It allows conducting genetic analyses for those intending to marry, newborn screening for the early detection of hereditary diseases, and screening for the early detection of breast cancer, colon, diabetes, heart, and arterial diseases,” he added.
The laboratory also includes devices to analyze wastewater and determine epidemic-affected areas, as well as areas that contain polluted materials, chemical waste, or narcotic substances.
The Minister also discussed with the visiting delegation the potential establishment of a new, modern laboratory in Badr City, Egypt. This facility would focus on genetic, water, and food testing, thereby bolstering the Egyptian health sector’s capabilities.
According to the statement, “With G42 Healthcare pushing the boundaries of health tech, such a development would undoubtedly be a significant leap forward for health industries in both Egypt and the UAE.”
G42 Healthcare
G42 Healthcare is a leading health-tech company on a mission to develop a world-class healthcare sector in the UAE and beyond. As the subsidiary of G42, the artificial intelligence (AI) and cloud computing company, G42 Healthcare aims to use AI, big data, and emerging technologies to enhance Abu Dhabi’s healthcare provision.
